Related Experiment Video
Updated: Sep 14, 2025
A Spheroid Killing Assay by CAR T Cells
Published on: December 12, 2018
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
Sara Sadat Aghamiri1, Rada Amin2
1Center for Brain, Biology and Behavior, University of Nebraska, Lincoln, NE 68503, USA.
Abstract:
CAR-T cell therapy is a personalized immunotherapy that has shown promising results in treating hematologic cancers. However, its therapeutic efficacy in solid cancers is often limited by tumor evasion mechanisms, resistance pathways, and an immunosuppressive tumor microenvironment. These challenges highlight the need for advanced predictive models to better capture the intricate interactions between CAR-T cells and tumors to enhance their potential. Digital Twins represent a transformative approach for optimizing CAR-T cell therapy by providing a virtual representation of the therapy-tumor trajectory using high-dimensional patient data. In this review, we first define Digital Twins and outline the fundamental steps in their development. We then explore the critical parameters required for designing CAR-T-specific Digital Twins. We examine published case studies demonstrating a few applications of Digital Twins in addressing key challenges in CAR-T cell therapy, including their impact on clinical trials and manufacturing processes. Finally, we discuss the limitations associated with integrating Digital Twins into CAR-T therapy. As Digital Twin technology continues to evolve, the potential to enhance CAR-T therapy through precision modeling and real-time adaptation could redefine the landscape of personalized cancer treatment.
Insights
Digital Twins offer a new way to improve CAR-T cell therapy for solid tumors. This approach uses patient data to create virtual models, overcoming challenges like tumor evasion and enhancing personalized cancer treatment.
Area of Science:
- Immunotherapy
- Computational Biology
- Oncology
Background:
- Chimeric antigen receptor (CAR)-T cell therapy shows promise for hematologic cancers.
- Solid tumors present challenges due to immune evasion, resistance, and immunosuppressive microenvironments.
- Advanced predictive models are needed to optimize CAR-T cell therapy for solid tumors.
Purpose of the Study:
- To review the concept and development of Digital Twins for CAR-T cell therapy.
- To explore parameters essential for CAR-T-specific Digital Twins.
- To examine applications and limitations of Digital Twins in CAR-T therapy.
Main Methods:
- Definition and development steps of Digital Twins.
- Identification of critical parameters for CAR-T-specific Digital Twins.
- Review of case studies on Digital Twin applications in CAR-T therapy.
Main Results:
- Digital Twins provide virtual representations of therapy-tumor interactions using high-dimensional patient data.
- Applications include addressing challenges in CAR-T therapy, clinical trials, and manufacturing.
- Limitations in integrating Digital Twins into CAR-T therapy were discussed.
Conclusions:
- Digital Twins have the potential to optimize CAR-T cell therapy by enabling precision modeling.
- Real-time adaptation through Digital Twins could significantly advance personalized cancer treatment.
- Further evolution of Digital Twin technology is expected to redefine CAR-T therapy.
